Authors: O'Dwyer, PJ Manola, J Valone, FH Ryan, LM Hines, JD Wadler, S Haller, DG Arbuck, SG Weiner, LM Mayer, RJ Benson, AB

Citation: Pj. O'Dwyer et al., Fluorouracil modulation in colorectal cancer: Lack of improvement with N-phosphonoacetyl-l-aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule - An Eastern Cooperative Oncology Group/Cancer and Leukemia Group B study, J CL ONCOL, 19(9), 2001, pp. 2413-2421

Authors: Laport, GG Valone, FH Zimmerman, TM Grinblatt, DL Van Vlasselaer, P Still, BJ Williams, SF

Citation: Gg. Laport et al., Transplantation with low-density autologous PBSC prepared with BDS60 for women with stage II, III and IV breast cancer, CYTOTHERAPY, 2(3), 2000, pp. 179-185

Authors: Burch, PA Breen, JK Buckner, JC Gastineau, DA Kaur, JA Laus, RL Padley, DJ Peshwa, MV Pitot, HC Richardson, RL Smits, BJ Sopapan, P Strang, G Valone, FH Vuk-Pavlovic, S

Citation: Pa. Burch et al., Priming tissue-specific cellular immunity in a phase I trial of autologousdendritic cells for prostate cancer, CLIN CANC R, 6(6), 2000, pp. 2175-2182

Authors: Small, EJ Fratesi, P Reese, DM Strang, G Laus, R Peshwa, MV Valone, FH

Citation: Ej. Small et al., Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells, J CL ONCOL, 18(23), 2000, pp. 3894-3903

Authors: Kaufman, PA Wallace, PK Valone, FH Wells, WA Memoli, VA Ernstoff, MS

Citation: Pa. Kaufman et al., Bispecific antibody MDX-210 for treatment of advanced ovarian and breast cancer, METH MOL M, 39, 2000, pp. 793-806